Detalles de la búsqueda
1.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med;
385(25): 2348-2360, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587382
2.
Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE Study.
J Clin Microbiol;
60(7): e0034722, 2022 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35758652
3.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Crit Care;
26(1): 355, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36380312
4.
Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failure.
J Med Virol;
91(1): 65-71, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30132922
5.
Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza.
Antimicrob Agents Chemother;
62(11)2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30150460
6.
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan.
Vaccine;
41(29): 4199-4205, 2023 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271703
7.
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial.
Int J Infect Dis;
114: 165-174, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688944
8.
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months.
J Clin Invest;
132(18)2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36106642
9.
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.
Front Immunol;
13: 1062067, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36713413
10.
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Nat Med;
27(11): 2032-2040, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34588689
11.
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
Lancet Infect Dis;
21(9): 1313-1323, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33894131
Resultados
1 -
11
de 11
1
Próxima >
>>